Title : [miR-29b Reduces Cisplatin Resistance of Gastric Cancer Cell by Targeting PI3K/Akt Pathway].

Pub. Date : 2015 Oct

PMID : 26564501






8 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 [miR-29b Reduces Cisplatin Resistance of Gastric Cancer Cell by Targeting PI3K/Akt Pathway]. Cisplatin microRNA 29b-1 Homo sapiens
2 OBJECTIVE: To investigate the regulatory effect of miR-29b on gastric cells" resistance to cisplatin. Cisplatin microRNA 29b-1 Homo sapiens
3 METHODS: The expression of miR-29b in gastric cancer cell line treated with cisplatin concentration gradient was detected using quantitative reverse-transcriptase polymerase chain reaction (qRT-PCR) and Western blotting. Cisplatin microRNA 29b-1 Homo sapiens
4 CCK8 was used to measure the cell viability after cisplatin treatment in condition of miR-29b knock-down and overexpression. Cisplatin microRNA 29b-1 Homo sapiens
5 RESULTS: The expression of miR-29b was significantly upregualted by cisplatin treatment,while its target gene AKT2 was downregulated. Cisplatin microRNA 29b-1 Homo sapiens
6 The up-regulation of miR-29b enhanced the sensitivity of gastric cancer cells to cisplatin,while the knock-down of miR-29b enhanced the cisplatin resistance. Cisplatin microRNA 29b-1 Homo sapiens
7 The up-regulation of miR-29b enhanced the sensitivity of gastric cancer cells to cisplatin,while the knock-down of miR-29b enhanced the cisplatin resistance. Cisplatin microRNA 29b-1 Homo sapiens
8 Rescue experiments demonstrated that the miR-29b might regulate cisplatin resistance of gastric cancer cell by targeting PI3K/Akt pathway. Cisplatin microRNA 29b-1 Homo sapiens